Evidence map›Paper›PMID 37089455›Full record

ArticleSpatial statistics2023

Analyzing COVID-19 data in the Canadian province of Manitoba: A new approach.

Leila Amiri, Mahmoud Torabi, Rob Deardon

Abstract read
In one paragraph

Article in Spatial statistics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leila AmiriDepartments of Community Health Sciences & Statistics, University of Manitoba, Winnipeg, Manitoba, Canada.
Mahmoud TorabiDepartments of Community Health Sciences & Statistics, University of Manitoba, Winnipeg, Manitoba, Canada.
Rob DeardonDepartment of Mathematics and Statistics & Faculty of Veterinary Medicine, University of Calgary, Calgary, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The basic homogeneous SEIR (susceptible-exposed-infected-removed) model is a commonly used compartmental model for analysing infectious diseases such as influenza and COVID-19. However, in the homogeneous SEIR model, it is assumed that the population of study is homogeneous and, one cannot incorporate individual-level information (e.g., location of infected people, distance between susceptible and infected individuals, vaccination status) which may be important in predicting new disease cases. Recently, a geographically-dependent individual-level model (GD-ILM) within an SEIR framework was developed for when both regional and individual-level spatial data are available. In this paper, we propose to use an SEIR GD-ILM for each health region of Manitoba (central Canadian province) population to analyse the COVID-19 data. As different health regions of the population under study may act differently, we assume that each health region has its own corresponding parameters determined by a homogeneous SEIR model (such as contact rate, latent period, infectious period). A Monte Carlo Expectation Conditional Maximization (MCECM) algorithm is used for inference. Using estimated parameters we predict the infection rate at each health region of Manitoba over time to identify highly risk local geographical areas. Performance of the proposed approach is also evaluated through simulation studies.

Indexed as

Expectation conditional maximization algorithmGeographically-dependent individual level modelInfectious diseasesSusceptible–exposed–infected–removed model

Identifiers

PMID37089455
PMCPMC10103593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.